Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call

Rhea-AI Summary

Cibus (Nasdaq: CBUS), an agricultural biotechnology company specializing in proprietary gene editing technologies for plant trait development in seeds, has scheduled its fourth quarter 2024 financial results announcement for March 20, 2025, after market close.

The company will host a conference call and audio webcast at 4:30 p.m. ET to discuss financial results and company updates. U.S. participants can dial +1-877-300-8521, while international participants can use +1-412-317-6026.

A replay will be available until April 3, 2025, accessible by dialing +1-844-512-2921 (U.S.) or +1-412-317-6671 (International) with passcode 10196898. The webcast and slides will be available on the company's investor website for 90 days after the event.

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2024 financial results on Thursday, March 20, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Title: Cibus, Inc. Fourth Quarter 2024 Results Conference Call
Event Date: Thursday, March 20, 2025        
Time: 4:30 p.m. ET        
Participant Numbers: +1-877-300-8521 (U.S.), +1-412-317-6026 (International)        
Event Link: https://investor.cibus.com/events

For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, April 3, 2025 and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 10196898.

A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus.

Cibus Contacts:

Investor Relations
Karen Troeber
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

Media Relations
Colin Sanford
colin@bioscribe.com
203-918-4347

FAQ

When will Cibus (CBUS) release its Q4 2024 earnings report?

Cibus will release its Q4 2024 earnings report on Thursday, March 20, 2025, after market close.

How can investors join the Cibus (CBUS) Q4 2024 earnings call?

Investors can join via phone (+1-877-300-8521 U.S., +1-412-317-6026 International) or webcast at investor.cibus.com on March 20, 2025, at 4:30 p.m. ET.

How long will the Cibus (CBUS) Q4 2024 earnings call replay be available?

The earnings call replay will be available until April 3, 2025, with slides and webcast archived on the company website for 90 days.

What is the replay passcode for Cibus (CBUS) Q4 2024 earnings call?

The replay passcode is 10196898, accessible by dialing +1-844-512-2921 (U.S.) or +1-412-317-6671 (International).